Beam Therapeutics
BEAM
#4141
Rank
โ‚น282.21 B
Marketcap
โ‚น2,743
Share price
3.61%
Change (1 day)
85.29%
Change (1 year)

Revenue for Beam Therapeutics (BEAM)

Revenue in 2026 (TTM): โ‚น14.79 Billion

According to Beam Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น15.69 Billion. In 2025 the company made a revenue of โ‚น12.54 Billion an increase over the revenue in the year 2024 that were of โ‚น5.44 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Beam Therapeutics from 2019 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น14.79 B17.96%
2025 โ‚น12.54 B130.22%
2024 โ‚น5.44 B-82.67%
2023 โ‚น31.44 B523.75%
2022 โ‚น5.04 B30.64%
2021 โ‚น3.85 B219748.21%
2020 โ‚น1.75 M36.74%
2019 โ‚น1.28 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA